{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:19:23Z","timestamp":1793042363577,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007192","name":"National Institute for Public Health and the Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["733032 HBM4EU"],"award-info":[{"award-number":["733032 HBM4EU"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000806","name":"European Environment Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environment International"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.envint.2022.107727","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T02:18:58Z","timestamp":1672798738000},"page":"107727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring"],"prefix":"10.1016","volume":"171","author":[{"given":"Wieneke","family":"Bil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Vandebriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zeilmaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Luijten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Marx-Stoelting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorhallur Ingi","family":"Halldorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Bokkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.envint.2022.107727_b0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00204-020-02715-4","article-title":"Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response","volume":"94","author":"Abraham","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.envint.2022.107727_b0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0045-6535(94)90324-7","article-title":"Toxic equivalency factors for dioxin-like PCBs: Report on WHO-ECEH and IPCS consultation, December 1993","volume":"28","author":"Ahlborg","year":"1994","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imr.12754","article-title":"The continuing story of T-cell independent antibodies","volume":"288","author":"Allman","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.envint.2022.107727_b0020","article-title":"Investigating the cytotoxicity of per-and polyfluoroalkyl substances in HepG2 cells: a Structure-Activity Relationship approach","volume":"153312","author":"Amstutz","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2022.107727_b0025","article-title":"Immunomodulation and exposure to per-and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies","volume":"1\u201325","author":"Antoniou","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"20","key":"10.1016\/j.envint.2022.107727_b0030","doi-asserted-by":"crossref","first-page":"2010747","DOI":"10.1002\/adfm.202010747","article-title":"Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells","volume":"31","author":"Asnaghi","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.envint.2022.107727_b0035","unstructured":"ATSDR. Toxicological profile for Perfluoroalkyls. 2021; doi: https:\/\/www.atsdr.cdc.gov\/ToxProfiles\/tp200.pdf (Accessed 07 July 2021)."},{"key":"10.1016\/j.envint.2022.107727_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106791","article-title":"Developing potency factors for thyroid hormone disruption by PFASs using TTR-TR\u03b2 CALUX\u00ae bioassay and assessment of PFASs mixtures in technical products","volume":"157","author":"Behnisch","year":"2021","journal-title":"Environ. Int."},{"issue":"7","key":"10.1016\/j.envint.2022.107727_b0055","doi-asserted-by":"crossref","DOI":"10.1289\/EHP10009","article-title":"Internal relative potency factors for the risk assessment of mixtures of Perfluoroalkyl Substances (PFAS) in human biomonitoring","volume":"130","author":"Bil","year":"2022","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.envint.2022.107727_b0050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/etc.4835","article-title":"Risk assessment of Per- and Polyfluoroalkyl Substance mixtures: A relative potency factor approach","volume":"40","author":"Bil","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/etc.5236","article-title":"Response to Letter to the Editor on Bil et al. 2021 \u201cRisk Assessment of Per\u2010and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach","volume":"41","author":"Bil","year":"2022","journal-title":"Environ. Toxicol. Chem."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yrtph.2009.03.004","article-title":"An integrated probabilistic framework for cumulative risk assessment of common mechanism chemicals in food: an example with organophosphorus pesticides","volume":"54","author":"Bosgra","year":"2009","journal-title":"Regul. Toxicol. Pharm."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yrtph.2013.11.012","article-title":"Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary","volume":"68","author":"Boverhof","year":"2014","journal-title":"Regul. Toxicol. Pharm."},{"issue":"4","key":"10.1016\/j.envint.2022.107727_b0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.reprotox.2011.08.004","article-title":"Toxicological evaluation of ammonium perfluorobutyrate in rats: twenty-eight-day and ninety-day oral gavage studies","volume":"33","author":"Butenhoff","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.envint.2022.107727_b0265","unstructured":"CDC, 1999. National Health and Nutrition Examination Survey Data. Department of Health and Human Services, Centers for Disease Control and Prevention. Hyattsville, MD. doi: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=1999 (Accessed 22 June 2022)."},{"key":"10.1016\/j.envint.2022.107727_b0270","unstructured":"CDC, 2003. National Health and Nutrition Examination Survey Data. Department of Health and Human Services, Centers for Disease Control and Prevention. Hyattsville, MD. doi: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2003 (Accessed 22 June 2022)."},{"key":"10.1016\/j.envint.2022.107727_b0275","unstructured":"CDC, 2005. National Health and Nutrition Examination Survey Data. Department of Health and Human Services, Centers for Disease Control and Prevention. Hyattsville, MD. doi: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2005 (Accessed 22 June 2022)."},{"key":"10.1016\/j.envint.2022.107727_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.envint.2022.107727_b0080","doi-asserted-by":"crossref","first-page":"107631","DOI":"10.1016\/j.envint.2022.107631","article-title":"Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat","author":"Conley","year":"2022","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2022.107727_b0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.toxlet.2021.09.002","article-title":"Suppression of Th2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice","volume":"351","author":"De Guise","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"10","key":"10.1016\/j.envint.2022.107727_b0095","first-page":"7555E","article-title":"Roadmap for Action on Risk Assessment of Combined Exposure to Multiple Chemicals (RACEMiC)","volume":"19","author":"De Jong","year":"2022","journal-title":"EFSA Supp. Publ."},{"key":"10.1016\/j.envint.2022.107727_b0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Eurosterone Meeting-Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.envint.2022.107727_b0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1289\/ehp.10896","article-title":"Perfluorooctanoic acid\u2013induced immunomodulation in adult C57BL\/6J or C57BL\/6N female mice","volume":"116","author":"DeWitt","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfp040","article-title":"Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice","volume":"109","author":"DeWitt","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/1547691X.2014.996682","article-title":"Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPAR \u03b1 and T-and B-cell targeting","volume":"13","author":"DeWitt","year":"2016","journal-title":"J. Immunotoxicol."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41370-018-0097-y","article-title":"Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence","volume":"29","author":"DeWitt","year":"2019","journal-title":"J. Eposure Sci. Environ. Epidemiol."},{"issue":"9","key":"10.1016\/j.envint.2022.107727_b0125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.envint.2022.107727_b0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00204-011-0661-x","article-title":"Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice","volume":"85","author":"Dong","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2022.107727_b0135","unstructured":"ECHA, 2011. Guidance on Information Requirements and Chemical Safety Assessment. Chapter R.4: Evaluation of Available Information. Version 1.1. Helsinki: Finland. doi: https:\/\/echa.europa.eu\/documents\/10162\/13643\/information_requirements_r4_en.pdf\/d6395ad2-1596-4708-ba86-0136686d205e (Accessed 25 June 2021)."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0140","first-page":"e04658","article-title":"Update: use of the benchmark dose approach in risk assessment","volume":"15","author":"EFSA","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.envint.2022.107727_b0150","unstructured":"Ehrlich, V., Bil, W., Vandebriel, R., et al., Submitted. Consideration of Pathways for Immunotoxicity of Per- and Polyfluoroalkyl Substances (PFAS). Environ. Health."},{"key":"10.1016\/j.envint.2022.107727_b0155","unstructured":"EMA, 2006. ICH Topic S8. Immunotoxicity studies for human pharmaceuticals. Note for guidance on immunotoxicity studies for human pharmaceuticals. CHMP\/167235\/2004. 2006; doi: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-s-8-immunotoxicity-studies-human-pharmaceuticals-step-5_en.pdf (Accessed 25 June 2021)."},{"issue":"9","key":"10.1016\/j.envint.2022.107727_b0145","first-page":"e06223","article-title":"Risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"EFSA","year":"2020","journal-title":"EFSA J."},{"issue":"3","key":"10.1016\/j.envint.2022.107727_b0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and Polyfluoroalkyl Substance toxicity and human health review: Current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/1547691X.2018.1445145","article-title":"Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1\/N mice when administered by oral gavage for 28 days","volume":"15","author":"Frawley","year":"2018","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.envint.2022.107727_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2018.01.011","article-title":"Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives","volume":"113","author":"Gomis","year":"2018","journal-title":"Environ. Int."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/toxsci\/kfaa123","article-title":"Application of a framework for grouping and mixtures toxicity assessment of PFAS: A closer examination of dose-additivity approaches","volume":"179","author":"Goodrum","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.envint.2022.107727_b0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.envint.2022.107727_b0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/1547691X.2012.755580","article-title":"Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood","volume":"10","author":"Granum","year":"2013","journal-title":"J. Immunotoxicol."},{"issue":"6","key":"10.1016\/j.envint.2022.107727_b0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2131\/jts.34.687","article-title":"Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice","volume":"34","author":"Guruge","year":"2009","journal-title":"J. Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.envint.2022.107727_b0195","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1289\/ehp.0900758","article-title":"A reexamination of the PPAR-\u03b1 activation mode of action as a basis for assessing human cancer risks of environmental contaminants","volume":"117","author":"Guyton","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107727_b0250","unstructured":"Haas, M.C., 2008. Memo Report HFPO Dimer Acid Ammonium Salt, A 28-Day Oral (Gavage) Toxicity Study of H-28397 in Rats with a 28-Day Recovery. DUPONT REPORT NUMBER 24447. doi: https:\/\/hero.epa.gov\/hero\/index.cfm\/reference\/download\/reference_id\/4221045 (Accessed 4 May 2018)."},{"key":"10.1016\/j.envint.2022.107727_b0255","unstructured":"Haas, M.C., 2009. Memo Report HFPO Dimer Acid Ammonium Salt, A 90-day oral (gavage) toxicicty study of H-28548 in rats with a 28-day recovery. DUPONT REPORT NUMBER 17751-1026. doi: https:\/\/hero.epa.gov\/hero\/index.cfm\/reference\/details\/reference_id\/4222142 (Accessed 4 May 2018)."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2131\/jts.37.63","article-title":"Repeated dose and reproductive\/developmental toxicity of perfluorooctadecanoic acid in rats","volume":"37","author":"Hirata-Koizumi","year":"2012","journal-title":"J. Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.envint.2022.107727_b0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/tox.21996","article-title":"Repeated dose and reproductive\/developmental toxicity of perfluorododecanoic acid in rats","volume":"30","author":"Kato","year":"2015","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/toxsci\/kfn015","article-title":"Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice","volume":"103","author":"Keil","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/1547691X.2015.1067259","article-title":"Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates","volume":"13","author":"Kielsen","year":"2016","journal-title":"J. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/rtph.1996.1076","article-title":"A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data","volume":"25","author":"Klimisch","year":"1997","journal-title":"Regul. Toxicol. Pharm."},{"issue":"23","key":"10.1016\/j.envint.2022.107727_b0225","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1080\/15287390802391943","article-title":"Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats","volume":"71","author":"Lefebvre","year":"2008","journal-title":"J. Toxic. Environ. Health A"},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/toxsci\/kft269","article-title":"Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate","volume":"138","author":"Looker","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2022.107727_b0235","unstructured":"Louisse, J., Fragki, S., Rijkers, D., et al., in preparation. Determination of in vitro relative potencies for a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/toxsci\/kfn113","article-title":"Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate","volume":"105","author":"Loveless","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/toxsci\/kfaa138","article-title":"Immunotoxicity of an electrochemically fluorinated aqueous film-forming foam","volume":"178","author":"McDonough","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10934529.2011.532418","article-title":"Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice","volume":"46","author":"Mollenhauer","year":"2011","journal-title":"J. Environ. Sci. Health A"},{"key":"10.1016\/j.envint.2022.107727_b0280","unstructured":"NTP, 2016. Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). Research Triangle Park, NC: National Toxicology Program. doi: https:\/\/ntp.niehs.nih.gov\/ntp\/ohat\/pfoa_pfos\/pfoa_pfosmonograph_508.pdf (Accessed 15 March 2021)."},{"key":"10.1016\/j.envint.2022.107727_b0285","unstructured":"NTP, 2019a. NTP technical report on the toxicity studies of perfluoroalkyl sulfonates (perfluorobutane sulfonic acid, perfluorohexane sulfonate potassium salt, and perfluorooctane sulfonic acid) administered by gavage to Sprague Dawley (Hsd:Sprague Dawley SD) rats. doi: https:\/\/ntp.niehs.nih.gov\/publications\/reports\/tox\/000s\/tox096\/index.html (Accessed 2 August 2022)."},{"key":"10.1016\/j.envint.2022.107727_b0290","unstructured":"NTP, 2019b. NTP technical report on the toxicity studies of perfluoroalkyl carboxylates (perfluorohexanoic acid, perfluorooctanoic acid, perfluorononanoic acid, and perfluorodecanoic acid) administered by gavage to Sprague Dawley (Hsd:Sprague Dawley SD) rats. doi: https:\/\/ntp.niehs.nih.gov\/publications\/reports\/tox\/000s\/tox097\/index.html (Accessed 2 August 2022)."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0295","first-page":"105","article-title":"Understanding and interpreting the serum protein electrophoresis","volume":"71","author":"O'Connell","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.envint.2022.107727_b0300","unstructured":"OECD, 2000. Series on Testing and Assessment no. 19. Guidance Document on the Recognition Asessment, and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation. ENV\/JM\/MONO(2000)7. doi: https:\/\/www.oecd-ilibrary.org\/docserver\/9789264078376-en.pdf?expires=1663508511&id=id&accname=ocid49027884&checksum=B4183F6301AAD45AC0A6366C98C2BE89 (Accessed 25 June 2021)."},{"key":"10.1016\/j.envint.2022.107727_b0400","doi-asserted-by":"crossref","unstructured":"OECD, 2008. Test No. 407 Repeated Dose 28-day Oral Toxicity Study in Rodens, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. doi: https:\/\/doi.org\/10.1787\/9789264070684-en (Accessed 25 June 2021).","DOI":"10.1787\/9789264070684-en"},{"key":"10.1016\/j.envint.2022.107727_b0405","doi-asserted-by":"crossref","unstructured":"OECD, 2018. Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. doi: https:\/\/doi.org\/10.1787\/9789264070707-en (Accessed 25 June 2021).","DOI":"10.1787\/9789264070707-en"},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","article-title":"Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate","volume":"104","author":"Peden-Adams","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0310","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0251","article-title":"The importance of MMR immunization in the United States","volume":"146","author":"Perrone","year":"2020","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.envint.2022.107727_b0315","doi-asserted-by":"crossref","first-page":"e0203330","DOI":"10.1371\/journal.pone.0203330","article-title":"Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy","volume":"13","author":"Pilkerton","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15476910801897474","article-title":"Urinary corticosterone as an indicator of stress-mediated immunological changes in rats","volume":"5","author":"Pruett","year":"2008","journal-title":"J. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.envint.2022.107727_b0325","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tox.2009.06.010","volume":"262","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"issue":"1\u20133","key":"10.1016\/j.envint.2022.107727_b0330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tox.2009.10.035","volume":"267","author":"Qazi","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2022.107727_b0335","unstructured":"Ramh\u00f8j, L., 2018. Developmental Toxicity of Perfluorohexane Sulfonate (PFHxS) - Effects on the Immune and Thyroid Hormone Systems. doi: https:\/\/backend.orbit.dtu.dk\/ws\/portalfiles\/portal\/162534912\/Ramh_j_2018_PhD_thesis_Developmental_Toxicity_of_PFHxS_Effects_on_the_Im.._.pdf (Accessed 15 September 2021)."},{"key":"10.1016\/j.envint.2022.107727_b0340","doi-asserted-by":"crossref","unstructured":"Reardon, A.J., Rowan-Carroll, A., Ferguson, S.S., et al., 2020. High-throughput transcriptomics and benchmark concentration modeling for potency ranking of per-and polyfluoroalkyl substances (PFAS) in exposed human liver cell spheroids. bioRxiv. Preprint ahead of press. doi: https:\/\/doi.org\/10.1101\/2020.10.20.347328.","DOI":"10.1101\/2020.10.20.347328"},{"key":"10.1016\/j.envint.2022.107727_b0345","doi-asserted-by":"crossref","unstructured":"Rietjens, I.M., Schriks, M., Houtman, C.J., Dingemans, M.M., van Wezel, A.P., 2022. Letter to the editor on Bil et al. 2021 \u201cRisk assessment of per\u2010and polyfluoroalkyl substance mixtures: A relative potency factor approach. Environ. Toxicol. Chem. 41(1), 7\u201312.","DOI":"10.1002\/etc.5232"},{"key":"10.1016\/j.envint.2022.107727_b0350","unstructured":"RIVM. PROAST Manual Menu Version, 2021. doi: https:\/\/www.rivm.nl\/documenten\/proast-manual-menu-version (Accessed 15 April 2022)."},{"key":"10.1016\/j.envint.2022.107727_b0355","article-title":"Acute immunotoxic effects of perfluorononanoic acid (PFNA) in C57BL\/6 mice","author":"Rockwell","year":"2013","journal-title":"Clin. Exp. Pharmacol."},{"key":"10.1016\/j.envint.2022.107727_b0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.fct.2016.12.004","article-title":"Persistent alterations in immune cell populations and function from a single dose of perfluorononanoic acid (PFNA) in C57Bl\/6 mice","volume":"100","author":"Rockwell","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0365","first-page":"179","article-title":"Evaluation of the immunomodulatory effects of 2, 3, 3, 3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL\/6 mice","volume":"156","author":"Rushing","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1547691X.2021.1922957","article-title":"Serum vaccine antibody concentrations in adults exposed to per-and polyfluoroalkyl substances: A birth cohort in the Faroe Islands","volume":"18","author":"Shih","year":"2021","journal-title":"J. Immunotoxicol."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0375","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/toxsci\/66.2.298","article-title":"Dose-response modeling of continuous endpoints","volume":"66","author":"Slob","year":"2002","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.envint.2022.107727_b0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10408444.2013.853726","article-title":"Shape and steepness of toxicological dose\u2013response relationships of continuous endpoints","volume":"44","author":"Slob","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2022.107727_b0390","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.envres.2016.05.020","article-title":"Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults","volume":"149","author":"Stein","year":"2016","journal-title":"Environ. Res."},{"issue":"2","key":"10.1016\/j.envint.2022.107727_b0385","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/pr.2015.213","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12\u201319 y: National Health and Nutrition Examination Survey","volume":"79","author":"Stein","year":"2016","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04091-z","article-title":"Perfluorooctane sulfonate affects intestinal immunity against bacterial infection","volume":"7","author":"Suo","year":"2017","journal-title":"Scientific reports."},{"issue":"8","key":"10.1016\/j.envint.2022.107727_b0410","doi-asserted-by":"crossref","DOI":"10.1289\/EHP6517","article-title":"Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of Guinea-Bissau children","volume":"128","author":"Timmermann","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2022.107727_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111712","article-title":"Concentrations of tetanus and diphtheria antibodies in vaccinated Greenlandic children aged 7\u201312 years exposed to marine pollutants, a cross sectional study","volume":"203","author":"Timmermann","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.envint.2022.107727_b0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2021.03.006","article-title":"Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice","volume":"233","author":"Torres","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.envint.2022.107727_b0425","doi-asserted-by":"crossref","first-page":"105235","DOI":"10.1016\/j.yrtph.2022.105235","article-title":"10% Body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis","author":"Van Berlo","year":"2022","journal-title":"Regul. Toxicol. Pharm."},{"issue":"4","key":"10.1016\/j.envint.2022.107727_b0430","doi-asserted-by":"crossref","DOI":"10.1289\/EHP9888","article-title":"Dose addition in the induction of craniofacial malformations in zebrafish embryos exposed to a complex mixture of food-relevant chemicals with dissimilar modes of action","volume":"130","author":"Van Der Ven","year":"2022","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.envint.2022.107727_b0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13596-013-0105-7","article-title":"Reversal of perfluorooctanesulfonate-induced immunotoxicity by a glucan-resveratrol-vitamin C combination","volume":"13","author":"Vetvicka","year":"2013","journal-title":"Orient Pharm Exp Med"},{"key":"10.1016\/j.envint.2022.107727_b0440","doi-asserted-by":"crossref","unstructured":"Vogs, C., Johanson, G., N\u00e4slund, M., et al., 2019. Toxicokinetics of perfluorinated alkyl acids influences their toxic potency in the zebrafish embryo (Danio rerio). Environ. Sci. Technol. 53(7), 3898\u20133907. doi: https:\/\/doi.org\/10.1021\/acs.est.8b07188.","DOI":"10.1021\/acs.est.8b07188"},{"key":"10.1016\/j.envint.2022.107727_b0445","unstructured":"WHO, 2012. Guidance for immunotoxicity risk assessment for chemicals. doi: https:\/\/apps.who.int\/iris\/handle\/10665\/330098 (Accessed 25 June 2021)."},{"issue":"5","key":"10.1016\/j.envint.2022.107727_b0450","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/toxics9050100","article-title":"Immunotoxicity of per-and polyfluoroalkyl substances: insights into short-chain PFAS exposure","volume":"9","author":"Woodlief","year":"2021","journal-title":"Toxics."},{"issue":"2\u20133","key":"10.1016\/j.envint.2022.107727_b0455","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1567-5769(01)00164-3","article-title":"Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid","volume":"2","author":"Yang","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.envint.2022.107727_b0460","unstructured":"Zeilmaker, M., Fragki, S., Verbruggen, E., Bokkers, B., Lijzen, J., 2018. Mixture exposure to PFAS: A relative potency factor approach. RIVM Report no. 2018-0070. doi: https:\/\/rivm.openrepository.com\/handle\/10029\/622164 (Accessed 20 September 2019)."},{"key":"10.1016\/j.envint.2022.107727_b0465","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.scitotenv.2019.01.325","article-title":"Prenatal exposure to perfluoroalkyl substances is associated with lower hand, foot and mouth disease viruses antibody response in infancy: Findings from the Guangzhou Birth Cohort Study","volume":"663","author":"Zeng","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.envint.2022.107727_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2019.113857","article-title":"Alternatives of perfluoroalkyl acids and hepatitis B virus surface antibody in adults: Isomers of C8 Health Project in China","volume":"259","author":"Zeng","year":"2020","journal-title":"Environ. Pollut."},{"issue":"7","key":"10.1016\/j.envint.2022.107727_b0475","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00204-008-0361-3","article-title":"Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL\/6 mice","volume":"83","author":"Zheng","year":"2009","journal-title":"Arch. Toxicol."}],"container-title":["Environment International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412022006547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412022006547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T12:36:56Z","timestamp":1758976616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0160412022006547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":95,"alternative-id":["S0160412022006547"],"URL":"https:\/\/doi.org\/10.1016\/j.envint.2022.107727","relation":{},"ISSN":["0160-4120"],"issn-type":[{"value":"0160-4120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring","name":"articletitle","label":"Article Title"},{"value":"Environment International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envint.2022.107727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107727"}}